This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.75% per year. These returns cover a period from January 1, 1988 through July 7, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
Universal Health (UHS) Q4 Earnings Beat, Revenues Up Y/Y
by Zacks Equity Research
Universal Health's (UHS) fourth-quarter results reflect improved revenues across the company's segments, partly offset by elevated costs.
Humana (HUM), Mercy Tie Up to Extend Telehealth Services
by Zacks Equity Research
Humana (HUM) partners with Mercy to expand virtual care services for members.
Centene's (CNC) Hawaii Arm to Keep Offering Healthcare Services
by Zacks Equity Research
Centene's (CNC) Hawaii subsidiary 'Ohana Health Plan is selected to continue catering services via the CSS plan.
Humana (HUM) to Offer Integrated Care to Specific MA Members
by Zacks Equity Research
Humana (HUM) unveils Humana Care Support driven by data and analytics in a bid to offer personalized care to a selected group of Medicare Advantage members.
Bear of the Day: Centene (CNC)
by Madeleine Johnson
This healthcare plan provider is hoping some recent acquisitions will kick start its recovery after a difficult 2020.
Humana (HUM) Joins IBM Watson Health to Aid Member Experience
by Zacks Equity Research
Humana (HUM) teams up with IBM Watson Health to leverage the latter's conversational AI solution for providing better information to Humana Employer Group members.
Cigna (CI) Q4 Earnings Miss, Decline Y/Y on Elevated Claims
by Zacks Equity Research
Cigna's (CI) Q4 results reflect higher revenues, partly offset by an increase in COVID-related claims that eroded its bottom line.
Company News for Feb 4, 2021
by Zacks Equity Research
Companies in The News Are: ABBV,SNE,HUM,SMG
Humana's (HUM) Q4 Loss Narrower Than Expected, Tumble Y/Y
by Zacks Equity Research
Humana's (HUM) fourth-quarter results reflect elevated costs related to COVID-19 along with high marketing expenses.
Anthem's (ANTM) Buyout to Offer Better Healthcare in Puerto Rico
by Zacks Equity Research
Anthem (ANTM) acquires subsidiaries of InnovaCare Health in a bid to facilitate improved health outcomes across Puerto Rico.
Humana (HUM) Reports Q4 Loss, Tops Revenue Estimates
by Zacks Equity Research
Humana (HUM) delivered earnings and revenue surprises of 2.13% and 1.26%, respectively, for the quarter ended December 2020. Do the numbers hold clues to what lies ahead for the stock?
Humana (HUM) to Report Q4 Earnings: What's in the Cards?
by Zacks Equity Research
Humana's (HUM) fourth-quarter 2020 earnings might have endured escalating COVID-related expenses, partly offset by better revenues.
Here's Why You Should Add Teladoc (TDOC) to Your Portfolio
by Zacks Equity Research
Teladoc (TDOC) has been benefiting from strong revenues, higher telehealth visits and robust cash balance.
Why is it Advisable to Hold on to Cigna (CI) Stock Now?
by Zacks Equity Research
Cigna (CI) looks poised to grow on the back of business rejig, which involves growing its healthcare business while lowering debt.
UnitedHealth (UNH) Enhances Virtual Care for Better Outcomes
by Zacks Equity Research
UnitedHealth (UNH) introduces virtual care offerings and expands services to boost telehealth visits.
Cigna (CI) to Gain From Integrated Benefits & Lower Costs
by Zacks Equity Research
Cigna (CI) reinforces the importance of integrated benefits, which has been reducing healthcare costs and resulting in improved health conditions.
Here's Why You Should Steer Clear of Centene (CNC) Stock Now
by Zacks Equity Research
Rising costs and poor financial leverage make Centene (CNC) an unattractive stock now.
UnitedHealth (UNH) to Buy Change Healthcare, Stock Gains
by Zacks Equity Research
UnitedHealth's (UNH) purchase of Change Healthcare, which will be combined with the company's subsegment OptumInsight, is likely to bolster the unit's capabilities.
Cigna (CI) Extends MA Network With Iora for Better Healthcare
by Zacks Equity Research
Cigna's (CI) MA network expands with the inclusion of Iora Health. The move intends to provide improved health outcomes for seniors.
Here's Why Hold Strategy is Apt For UnitedHealth Group (UNH)
by Zacks Equity Research
UnitedHealth Group (UNH) remains well-poised to benefit from growing revenues, robust Medicare business and a solid cash balance.
Teladoc Health (TDOC), WTI to Gain from Intel's Investment
by Zacks Equity Research
Teladoc Health (TDOC) continues to help WTI through the former's virtual platform, with the recent investment of Intel ramping up the work process of both the healthcare providers.
Teladoc (TDOC) Up 130% YTD: Will the Rally Continue in 2021?
by Zacks Equity Research
Buoyancy in demand for telehealth consultation services along with a sturdy inorganic growth story will continue to push Teladoc's (TDOC) stock higher in 2021.
Centene (CNC) to Purchase Specialty Pharmacy PANTHERx Rare
by Zacks Equity Research
Centene (CNC) to buy specialty pharmacy PANTHERx Rare to penetrate the specialty drug market and cater to patients with complex situations.
Here's Why You Should Hold Cigna (CI) Stock in Your Portfolio
by Zacks Equity Research
Cigna (CI) remains well-poised for growth on the back of a strong Medicare business and adequate cash generation capabilities.
3 Health Insurers That Crushed S&P YTD, Set to Rise Further
by Srijita Guha
We zero in on three health insurers that outperform the S&P Index YTD on the back of solid fundamentals. All these stocks hold prospects to continue the rally going forward.